These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Specific in vitro binding of a new (99m)Tc-radiolabeled derivative of the C-terminal decapeptide of prothymosin alpha on human neutrophils. Karachaliou CE; Liolios C; Triantis C; Zikos C; Samara P; Tsitsilonis OE; Kalbacher H; Voelter W; Papadopoulos M; Pirmettis I; Livaniou E Int J Pharm; 2015; 486(1-2):1-12. PubMed ID: 25796124 [TBL] [Abstract][Full Text] [Related]
6. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro. Samara P; Ioannou K; Neagu M; Arnogiannaki N; Ardavanis A; Voelter W; Tsitsilonis O Int Immunopharmacol; 2013 Jan; 15(1):50-7. PubMed ID: 23201434 [TBL] [Abstract][Full Text] [Related]
7. Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice. Voutsas IF; Pistamaltzian N; Tsiatas ML; Skopeliti M; Katsila T; Mavrothalassiti I; Spyrou S; Dimopoulos MA; Tsitsilonis OE; Bamias A Eur J Cancer; 2013 May; 49(7):1706-14. PubMed ID: 23276721 [TBL] [Abstract][Full Text] [Related]
8. Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications? Samara P; Ioannou K; Tsitsilonis OE Vitam Horm; 2016; 102():179-207. PubMed ID: 27450735 [TBL] [Abstract][Full Text] [Related]
9. Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteria. Samara P; Kalbacher H; Ioannou K; Radu DL; Livaniou E; Promponas VJ; Voelter W; Tsitsilonis O J Immunol Methods; 2013 Sep; 395(1-2):54-62. PubMed ID: 23831611 [TBL] [Abstract][Full Text] [Related]
10. The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients. Skopeliti M; Voutsas IF; Klimentzou P; Tsiatas ML; Beck A; Bamias A; Moraki M; Livaniou E; Neagu M; Voelter W; Tsitsilonis OE Cancer Immunol Immunother; 2006 Oct; 55(10):1247-57. PubMed ID: 16453152 [TBL] [Abstract][Full Text] [Related]
11. In vivo biodistribution and imaging studies with a Karachaliou CE; Triantis C; Liolios C; Palamaris L; Zikos C; Tsitsilonis OE; Kalbacher H; Voelter W; Loudos G; Papadopoulos M; Pirmettis I; Livaniou E Eur J Pharm Biopharm; 2017 Apr; 113():188-197. PubMed ID: 28087377 [TBL] [Abstract][Full Text] [Related]
12. Prothymosin Alpha: An Alarmin and More.. Samara P; Karachaliou CE; Ioannou K; Papaioannou NE; Voutsas IF; Zikos C; Pirmettis I; Papadopoulos M; Kalbacher H; Livaniou E; Tsitsilonis OE; Voelter W Curr Med Chem; 2017; 24(17):1747-1760. PubMed ID: 28521686 [TBL] [Abstract][Full Text] [Related]
16. A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis. Samara P; Miriagou V; Zachariadis M; Mavrofrydi O; Promponas VJ; Dedos SG; Papazafiri P; Kalbacher H; Voelter W; Tsitsilonis O Oncotarget; 2017 Jul; 8(30):48635-48649. PubMed ID: 28611290 [TBL] [Abstract][Full Text] [Related]
17. Generation of mature Nα-terminal acetylated thymosin α 1 by cleavage of recombinant prothymosin α. Liu B; Gong X; Chang S; Sun P; Wu J ScientificWorldJournal; 2013; 2013():387282. PubMed ID: 24288480 [TBL] [Abstract][Full Text] [Related]